LGR5 and cancer: We also confirmed that YTHDF1 promoted CD133 and LGR5 expression in CSCs, xenograft models, and CSC-specific Ythdf1 knock-in/knockout mice, suggesting that YTHDF1 directly boosts cancer stemness properties.